AHRQ Patient Safety Network ► FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

AHRQ Patient Safety Network





FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

FDA Safety Communication. Silver Spring, MD: US Food and Drug Administration; February 25, 2015.

The practice of using multi-dose insulin pens, meant for single patient use only, among multiple patients has been linked to health care–associated infections. This announcement outlines federal labeling requirements to raise awareness of the risks associated with this practice to prevent misuse of the devices.

Free full text 
Information (PDF) 

Related Resources

STUDY

Nonfatal, unintentional medication exposures among young children—United States, 2001–2003.

Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. January 13, 2006;55:1-5.

AUDIOVISUAL

Possible dose-counter errors with the Asmanex Twisthaler.

Food and Drug Administration (FDA) Patient Safety News. Show #61. March 2007.

COMMENTARY

Confusion with Acetaminophen

Heubi JE. AHRQ WebM&M [serial online]. January 2006.

COMMENTARY

Language Barrier

Flores G. AHRQ WebM&M [serial online]. April 2006.

View all related resources...